PubMed Health⌕ Search

Biomedical subjects

A Salcedo Posadas

Publications and source records attributed to A Salcedo Posadas.

9 recordsLinked to original sources
PubMed2003

[Complementary therapies in cystic fibrosis: evidence of therapeutic benefits and treatment recommendations].

Cystic fibrosis (CF) is an autosomal-recessive disorder that predominantly affects the respiratory system. When this disease was described in 1938 the mortality rate was approximately 70 % in the first year of life. Survival has dramatically increased from a median of approximately 4 years in the 1960s to 19 years in the 1970s and 33 years in 2001 according to figures from the American Cystic Fibrosis Foundation. This impressive increase in the life expectancy of individuals with CF is undoubtedly related to recent advances in the organization of specialized CF units and to the use of new therapies against respiratory involvement.The traditional basis of treatment for CF lung disease includes nutritional support, antibiotic therapy, chest physical therapy and aerobic exercise. Preventive measures such as influenza vaccination and avoidance of tobacco smoke are also useful. Several new approaches such as ion transport therapy, protein therapy and gene therapy are currently being developed. Many studies have provided clear evidence of the therapeutic benefits of antibiotics, respiratory physiotherapy, exercise, and nutrition. In this article we review the scientific evidence on the advantages of the use of several therapeutic interventions against inflammation, increased sputum viscoelasticity and adhesiveness, and bronchial obstruction in CF patients.

Azithromycin↗
PubMed2001

[Management of parapneumonic pleural effusions].

Pleural effusion in children is most often due to bacterial pneumonia. Between 0.6 and 2% of pneumonias are complicated by empyema and approximately 40% of children hospitalized with pneumonia have a pleural effusion. In recent years Streptococcus pneumoniae is the most prevalent organism. Treatment is based on the early and judicious use of antibiotics, imaging techniques, thoracocentesis, pleural drainage, fibrinolytics, thoracoscopy and thoracotomy. Indications for early pleural drainage are gross pus, positive Gram stain in pleural fluid, pleural glucose less than 50mg/dL, pleural fluid pH of less than 7 and sonographic evidence of loculations. Local fibrinolytics may decrease the need for surgical treatment, with a success rate between 38 and 100%, according to the effusion stage. Thoracoscopic debridement is useful in the fibrinopurulent stage with loculations, with favorable results in 30-100% of patients, also depending on the effusion stage.

Algorithms↗
PubMed1999

[Reproducibility of the walking test in patients with cystic fibrosis].

OBJECTIVE: The walking test is a useful and objective method for evaluating the tolerance for exercise in patients with chronic bronchopulmonary diseases. Our objective was to check the reproducibility of this test and evaluate whether there are differences between tests of varying duration (2 and 6 minutes) in a group of patients with cystic fibrosis. PATIENTS AND METHODS: We utilized the walking test on 29 patients who were in a stable phase and under care in the Cystic Fibrosis Unit of our hospital. Two tests were carried out, one of 2 minutes and the other of 6 minutes duration, both of which were repeated after a 15-minute interval. RESULTS: The reproducibility of the walking test in this type of patient was very good and we found an excellent correlation between the two-minute test and the six-minute test. We did not observe a training effect when the test was repeated. CONCLUSIONS: The two minute walking test has a high reproducibility and we propose this test, because it is shorter and more comfortable for pediatric patients with cystic fibrosis, in order to evaluate the evolution, progressive deterioration of the of the patient and the response to different types of treatments.

Adolescent↗
PubMed1998

[Assessment of lung function using forced impulse oscillometry in cystic fibrosis patients].

The aim of this study was to evaluate the usefulness of forced impulse oscillometry to measure airway resistance in patients with cystic fibrosis. Thirty-four patients (20 men) with a mean age of 15 +/- 4 years were studied. All patients underwent forced impulse oscillometry, forced spirometry and body plethysmography. Correlations among spirometric, plethysmographic and oscillometric variables were analyzed. We found a statistically significant relation between both forced expiratory volume in one second (FEV1) and total airway resistance (Raw) and the following oscillometric variables: impedance (Zrs), resonance frequency (Fres), resistance to 5 hertz (Rrs5) and reactance to 5 hertz (Xrs5). The measurements that correlated most highly with classical pulmonary function tests were Zrs and Xrs5. Both resistance (Rrs) and reactance (Xrs) of the respiratory system were dependent on frequency. Their correlation with FEV1 and Raw were therefore lower when frequencies above 5 hertz were used. We conclude that airway resistances of cystic fibrosis patients can be adequately estimated by forced impulse oscillometry. This technique is a promising test of pulmonary function in such patients.

Adolescent↗
PubMed1989

[Spontaneous chylothorax: seven cases of prenatal diagnosis].

Authors present 7 cases of spontaneous congenital chylothorax, all of them diagnosed antepartum echographycally. Six of them needed cardiopulmonary resucitation but none presented fetal anoxia. Three cases had associated malformations. Treatment included thoracocenthesis, pleural drainage, assisted ventilation and appropriate nutrition. Pleural effusion lasted from 14 days to 6 months. Complications were: pneumothorax, metabolic acidosis and bacterial infections. Three patients died by respiratory failure. Pulmonary hypoplasia was present in two of them, and suspected in the third one. Survivors are free of symptoms.

Chylothorax↗